U.S. Markets open in 1 hr 29 mins

Proteome Sciences plc (PRM.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
3.425+0.050 (+1.481%)
As of 4:30PM BST. Market open.

Proteome Sciences plc

Hamilton House
Mabledon Place
London WC1H 9BB
United Kingdom

http://www.proteomics.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees36

Key Executives

NameTitlePayExercisedAge
Dr. Jeremy Rupert Michael HaighCEO & Exec. Director146kN/A56
Dr. Ian H. PikeChief Scientific Officer & Exec. DirectorN/AN/AN/A
Dr. Josef SchwarzChief Compliance Officer and Exec. DirectorN/AN/AN/A
Mr. Glenn BarneyVP of Sales & Marketing and VP of Bus. Devel. UsN/AN/AN/A
Mr. Malcolm WardChief Technical Officer of London Research FacilityN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Proteome Sciences plc, a life sciences company, engages in the research and development of biomarkers. The company delivers content for personalized medicine in the areas of biomarker services, biomarker assays, isobaric and isotopic reagents, and proprietary biomarkers. It offers PS Biomarker Services to the pharmaceutical, biotechnology, and diagnostics industries for biomarkers discovery, validation, and measurement in clinical trials and in vitro diagnostics. The company also develops various proprietary biomarkers for a range of human diseases, including CNS disorders comprising Alzheimer’s, Huntington’s, stroke, traumatic brain injury, TSE’s, and pain; oncology consisting of lung, breast, esophageal, colorectal cancers, and neuroblastoma; and organ transplant rejection, such as renal and cardiac diseases. In addition, it provides protein tags and assays for spectrometry analysis; and develops isobaric and isotopic reagents under the Tandem Mass Tag brand. Further, the company’s biomarker services include proteomics and peptidomics. It operates in the United Kingdom, Germany, and the United States. Proteome Sciences plc was incorporated in 1993 and is headquartered in London, the United Kingdom.

Corporate Governance

Proteome Sciences plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.